C57BL/6JCya-Crip1em1flox/Cya
Common Name
Crip1-flox
Product ID
S-CKO-18201
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-12925-Crip1-B6J-VA
When using this mouse strain in a publication, please cite “Crip1-flox Mouse (Catalog S-CKO-18201) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Crip1-flox
Strain ID
CKOCMP-12925-Crip1-B6J-VA
Gene Name
Product ID
S-CKO-18201
Gene Alias
CRHP, CRP1, Crip
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
Chr 12
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000006523
NCBI RefSeq
NM_007763
Target Region
Exon 2~5
Size of Effective Region
~1.6 kb
Overview of Gene Research
CRIP1, also known as cysteine-rich intestinal protein 1, encodes a member of the LIM/double zinc finger protein family. It is involved in regulating diverse cellular processes such as cell growth, development, and differentiation. CRIP1 is associated with multiple signaling pathways including NF-κB, Wnt/β-catenin, and is important in maintaining protein homeostasis [1,2,5,7]. Genetic models, especially KO/CKO mouse models, could potentially offer insights into its functions.
In pancreatic ductal adenocarcinoma (PDAC), CRIP1 upregulation fosters MDSC trafficking and an immunosuppressive tumor microenvironment by facilitating NF-κB/p65 nuclear translocation [1]. In hepatocellular carcinoma (HCC), it promotes cancer stem-like properties by suppressing BBOX1-mediated carnitine metabolism [2]. In gastric cancer, CRIP1 overexpression promotes lymphangiogenesis and lymphatic metastasis by phosphorylating CREB1 and regulating VEGFC and CCL5 expression [3]. In multiple myeloma, high CRIP1 expression is linked to unfavorable outcomes, and it dual-regulates proteasome and autophagy activities [4]. In osteoporosis, reduced CRIP1 expression in bone marrow stromal cells (BMSCs) impairs osteogenic differentiation, while overexpression enhances it via the Wnt signaling pathway [5]. In acute myeloid leukemia (AML), high CRIP1 expression is related to lower remission rates and shorter survival, and in AML-M5 subtype cells, it supports growth and migration by activating the Wnt/β-catenin pathway [6,7]. In gastric cancer, CRIP1 promotes homologous repair upon DNA damage from chemotherapy by cooperating with BRCA2 to enrich nuclear RAD51 [8].
In conclusion, CRIP1 is a crucial regulator in various biological processes and diseases. Through model-based research, its roles in tumorigenesis, immune regulation, bone metabolism, and leukemia development have been revealed. The use of KO/CKO mouse models could further clarify its functions in these disease areas, providing potential therapeutic targets for PDAC, HCC, gastric cancer, multiple myeloma, osteoporosis, and AML.
References：
1. Liu, Xiaomeng, Tang, Rong, Xu, Jin, Yu, Xianjun, Shi, Si. 2023. CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma. In Gut, 72, 2329-2343. doi:10.1136/gutjnl-2022-329349. https://pubmed.ncbi.nlm.nih.gov/37541772/
2. Wang, Jing, Zhou, Yan, Zhang, Donghui, Wang, Hui, Zhao, Liang. 2022. CRIP1 suppresses BBOX1-mediated carnitine metabolism to promote stemness in hepatocellular carcinoma. In The EMBO journal, 41, e110218. doi:10.15252/embj.2021110218. https://pubmed.ncbi.nlm.nih.gov/35775648/
3. Wu, Zhonghua, Qu, Bicheng, Yuan, Minxian, Song, Yongxi, Wang, Zhenning. 2023. CRIP1 Reshapes the Gastric Cancer Microenvironment to Facilitate Development of Lymphatic Metastasis. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2303246. doi:10.1002/advs.202303246. https://pubmed.ncbi.nlm.nih.gov/37409440/
4. Tang, Peixia, Yu, Zhen, Sun, Hao, Qiu, Lugui, Hao, Mu. 2024. CRIP1 involves the pathogenesis of multiple myeloma via dual-regulation of proteasome and autophagy. In EBioMedicine, 100, 104961. doi:10.1016/j.ebiom.2023.104961. https://pubmed.ncbi.nlm.nih.gov/38199044/
5. Chen, Ruge, Jin, Yangchen, Lian, Ru, Zhang, Zhongmin, Zhao, Liang. 2024. CRIP1 regulates osteogenic differentiation of bone marrow stromal cells and pre-osteoblasts via the Wnt signaling pathway. In Biochemical and biophysical research communications, 727, 150277. doi:10.1016/j.bbrc.2024.150277. https://pubmed.ncbi.nlm.nih.gov/38936225/
6. Ma, Bei-Bei, Zhang, Ting-Juan, Wang, Cui-Zhu, Lin, Jiang, Qian, Jun. 2020. Methylation-independent CRIP1 expression is a potential biomarker affecting prognosis in cytogenetically normal acute myeloid leukemia. In American journal of translational research, 12, 4840-4852. doi:. https://pubmed.ncbi.nlm.nih.gov/33042393/
7. Deng, Xiaoling, Zeng, Yanmei, Qiu, Xiaofen, Zhang, Jingdong, Chen, Xiaoli. 2023. CRIP1 supports the growth and migration of AML-M5 subtype cells by activating Wnt/β-catenin pathway. In Leukemia research, 130, 107312. doi:10.1016/j.leukres.2023.107312. https://pubmed.ncbi.nlm.nih.gov/37224580/
8. Sun, Huiying, Zhou, Rui, Zheng, Yannan, Shi, Min, Liao, Wangjun. 2021. CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapy. In Oncogene, 40, 5342-5355. doi:10.1038/s41388-021-01932-0. https://pubmed.ncbi.nlm.nih.gov/34262130/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.